[{"NetIncomeLoss_1_Q1_USD":-33015000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":16363000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":132165014.0,"CommitmentsAndContingencies_0_Q1_USD":null,"DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_0_Q1_USD":400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-101000.0,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q1_USD":2800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":96798000.0,"Depreciation_1_Q1_USD":1918000.0,"PaymentsToAcquireInvestments_1_Q1_USD":149052000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":59000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":8430000.0,"AssetsCurrent_0_Q1_USD":716061000.0,"OperatingLeaseExpense_1_Q1_USD":2007000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":21900607.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":4060000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":8168000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-369000.0,"CommonStockSharesIssued_0_Q1_shares":141470075.0,"Assets_0_Q1_USD":1179044000.0,"ShareBasedCompensation_1_Q1_USD":16792000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":40189000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":17212410.0,"OperatingLeaseLiability_0_Q1_USD":54686000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-292000.0,"Liabilities_0_Q1_USD":109265000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":5044000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":799000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":55183000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":86211000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":268249000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":5200000.0,"ProceedsFromStockPlans_1_Q1_USD":1984000.0,"OtherExpenses_1_Q1_USD":325000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":511000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-1911000.0,"CommonStockValue_0_Q1_USD":141000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":264573000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":710000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":6044000.0,"TenantImprovements_0_Q1_USD":5000000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":964200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-33384000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":4152000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":6275000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":236865000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":51625000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1749097000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":4060000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-38753000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":8509000.0,"CommonStockSharesOutstanding_0_Q1_shares":141470075.0,"RestrictedCashNoncurrent_0_Q1_USD":9449000.0,"PaymentsToAcquireEquityMethodInvestments_1_Q1_USD":15938000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":14825000.0,"PaymentsForProceedsFromTenantAllowance_1_Q1_USD":-1111000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":16792000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-49328000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":7917000.0,"LiabilitiesCurrent_0_Q1_USD":54849000.0,"AccountsPayableCurrent_0_Q1_USD":14875000.0,"NonoperatingIncomeExpense_1_Q1_USD":186000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":246314000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":16480000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.084,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q1_USD":19351000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":176627000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1984000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":0.0,"OperatingLeasePayments_1_Q1_USD":1000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":8299000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":123146000.0,"PaymentsForLeasingCostsCommissionsAndTenantImprovements_1_Q1_USD":966000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":31200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":53514000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-679358000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-740000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":38345000.0,"OperatingIncomeLoss_1_Q1_USD":-33201000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":462716000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":239000.0,"PreferredStockValue_0_Q1_USD":0.0,"OperatingLeaseCost_1_Q1_USD":1862000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1179044000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":16792000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":137971000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3061000.0,"OperatingExpenses_1_Q1_USD":71546000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-4314000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.25,"ProfitLoss_1_Q1_USD":-33015000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2791000.0,"StockholdersEquity_0_Q1_USD":1069779000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":6461000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":903575000.0,"VariableLeaseCost_1_Q1_USD":327000.0,"LeaseCost_1_Q1_USD":2189000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q1_USD":4100000.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]